Intramuscular Injector Market

Intramuscular injector is an injecting device used to delivering medications deep into the muscles. At present, intramuscular injectors are used in modern medicine to enable quick absorption of medication in the bloodstream. Generally, these injectors are used to deliver vaccines and drugs. In addition, these are highly preferred to other drug delivery routes for quick treatment, as muscle tissues have higher blood supply as compared to the tissues present under the skin and muscles are capable of holding high volume of medication.

Intramuscular Injector Market contains market size and forecasts of Intramuscular Injector in global, including the following market information:

• Global Intramuscular Injector Market Revenue, 2017-2022, 2023-2028, ($ millions)
• Global Intramuscular Injector Market Sales, 2017-2022, 2023-2028, (K Units)
• Global top five Intramuscular Injector companies in 2021 (%)

The global Intramuscular Injector market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Pre-fillable Injection System Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Intramuscular Injector include Antares Pharma, Endo International Plc, Bioject Medical Technologies, PharmaJetMedical International Technology, National Medical Products, Valeritas, European Pharma Group, PenJet Corporation and Becton, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

We surveyed the Intramuscular Injector manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Intramuscular Injector Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Intramuscular Injector Market Segment Percentages, by Type, 2021 (%)

• Pre-fillable Injection System
• Fillable Needle-free Injectors

Global Intramuscular Injector Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Intramuscular Injector Market Segment Percentages, by Application, 2021 (%)

• Hospitals
• Clinics
• Ambulatory Surgery Centers
• Others

Global Intramuscular Injector Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Intramuscular Injector Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

• Key companies Intramuscular Injector revenues in global market, 2017-2022 (Estimated), ($ millions)
• Key companies Intramuscular Injector revenues share in global market, 2021 (%)
• Key companies Intramuscular Injector sales in global market, 2017-2022 (Estimated), (K Units)
• Key companies Intramuscular Injector sales share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Antares Pharma
• Endo International Plc
• Bioject Medical Technologies
• PharmaJetMedical International Technology
• National Medical Products
• Valeritas
• European Pharma Group
• PenJet Corporation
• Becton
• Dickinson
• Injex Pharma AG
• Crossject SA
• Solace Biotech
• Sanify Healthcare Private Limited
• Novosanis
• Vata
• Kaleo